The Experimental Antitumor Agents Phortress and Doxorubicin are Equiactive Against Human-Derived Breast Carcinoma Xenograft Models

[1]  I. Fichtner,et al.  Establishment and characterization of a new human oestradiol- and progesterone-receptor-positive mammary carcinoma serially transplantable in nude mice , 2005, Journal of Cancer Research and Clinical Oncology.

[2]  I. Fichtner,et al.  Establishment and characteristics of two new human mammary carcinoma lines serially transplantable in nude mice , 2005, Journal of Cancer Research and Clinical Oncology.

[3]  I. Fichtner,et al.  Establishment and characteristics of two new human mammary carcinoma lines in nude mice with special reference to the estradiol receptor status and the importance of stroma forin vivo andin vitro growth , 2004, Breast Cancer Research and Treatment.

[4]  E. Sausville,et al.  Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4-amino-3-methylphenyl]-5-fluoro-benzothiazole: a potential surrogate marker for patient sensitivity. , 2003, Molecular cancer therapeutics.

[5]  E. Sausville,et al.  Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole. , 2003, Molecular pharmacology.

[6]  P. Cooper,et al.  Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo , 2003, British Journal of Cancer.

[7]  E. Sausville,et al.  In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3-methylphenyl)benzothiazoles , 2002, British Journal of Cancer.

[8]  E. Sausville,et al.  Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles. , 2002, Molecular cancer therapeutics.

[9]  M. Stevens,et al.  Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs. , 2002, Journal of medicinal chemistry.

[10]  E. Sausville,et al.  Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole. , 2002, Molecular pharmacology.

[11]  M. Stevens,et al.  Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles. , 2001, Journal of medicinal chemistry.

[12]  E. Sausville,et al.  Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells. , 2000, Cancer research.

[13]  M. Stevens,et al.  Mechanisms of acquired resistance to 2-(4-aminophenyl)benzothiazole (CJM 126, NSC 34445) , 2000, British Journal of Cancer.

[14]  I. Fichtner,et al.  Development and characterization of a tamoxifen-resistant breast carcinoma xenograft , 2000, British Journal of Cancer.

[15]  E. Sausville,et al.  Role of CYP 1 A 1 in Modulation of Antitumor Properties of the Novel Agent 2-( 4-Amino-3-methylphenyl ) benzothiazole ( DF 203 , NSC 674495 ) in Human Breast Cancer Cells 1 , 2000 .

[16]  K. Paull,et al.  2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity. , 1998, British Journal of Cancer.

[17]  P. Strickland,et al.  Metabolism of 2-amino-1-methyl-6-phenylimidazo [ 4 , 5b ] pyridine by human cytochrome P 4501 A 1 , P 4501 A 2 and P 4501 B 1 , 1998 .

[18]  S Wrigley,et al.  Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. , 1996, Journal of medicinal chemistry.

[19]  I. Fichtner,et al.  Establishment and Characterization of Human Xenotransplanted Breast Carcinoma Lines: Use for the Screening of Alkylphosphocholines (APC) , 1996 .

[20]  F. Guengerich.  The 1992 Bernard B. Brodie Award Lecture. Bioactivation and detoxication of toxic and carcinogenic chemicals. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[21]  R. Shoemaker,et al.  A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. , 1988, Molecular endocrinology.

[22]  W. Pratt,et al.  The Anticancer Drugs , 1979 .

[23]  A. Long,et al.  A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.